Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/1471-2407-14-323
Published Online: 2014-05-07
Published Print: 2014-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Buchler, Tomas
Pavlik, Tomas
Melichar, Bohuslav
Bortlicek, Zbynek
Usiakova, Zuzana
Dusek, Ladislav
Kiss, Igor
Kohoutek, Milan
Benesova, Vera
Vyzula, Rostislav
Abrahamova, Jitka
Obermannova, Radka
License valid from 2014-05-07